Differential effects of IL-17 pathway in disseminated candidiasis and zymosan-induced multiple organ failure

Shock

Volumn 34, Issue 4, 2010, Pages 407-411

  Van De Veerdonk, Frank L ^a   Kullberg, Bart Jan ^a   Verschueren, Ineke C ^a   Hendriks, Thijs ^a   Van Der Meer, Jos W M ^a   Joosten, Leo A B ^a   Netea, Mihai G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Candida; fungal sepsis; IL 17; IL 17RA

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; CELL SUBPOPULATION; CYTOKINE PRODUCTION; HOST RESISTANCE; INVASIVE CANDIDIASIS; MOUSE; MULTIPLE ORGAN FAILURE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS;

ANIMALS; CANDIDIASIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-17; MICE; MICE, KNOCKOUT; MULTIPLE ORGAN FAILURE; PHAGOCYTOSIS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; ZYMOSAN;

EID: 77955708325     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181d67041     Document Type: Article

References (29)

1. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, Oliver P, Huang W, Zhang P, Zhang J, et al.: Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194(4): 519-527, 2001.
2. Ouyang W, Kolls JK, Zheng Y: The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28(4):454-467, 2008.
3. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR, Weaver CT: Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441(7090):231-234, 2006.
4. Marodi L, Korchak HM, Johnston RB Jr: Mechanisms of host defense against Candida species. 1. Phagocytosis by monocytes and monocyte-derived mac-rophages. J Immunol 146(8):2783-2789, 1991.
5. Kullberg BJ, Van 't Wout JW, Van Furth R: Role of granulocytes in enhanced host resistance to Candida albicans induced by recombinant interleukin-1. Infect Immun 58(10):3319-3324, 1990.
6. Huang W, Na L, Fidel PL, Schwarzenberger P: Requirement for interleukin-17A for systemic antiYCandida albicans host defense in mice. J Infect Dis 190:524-631, 2004.
7. Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW, Hai JH, Yu JJ, Jung JW, et al.: Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 206(2): 299-311, 2009.
8. Werner JL, Metz AE, Horn D, Schoeb TR, Hewitt MM, Schwiebert LM, Faro-Trindade I, Brown GD, Steele C: Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus. J Immunol 182(8):4938-4946, 2009.
9. Loures FV, Pina A, Felonato M, Calich VL: TLR2 is a negative regulator of Th17 cells and tissue pathology in a pulmonary model of fungal infection. J Immunol 183(2):1279-1290, 2009.
10. Zelante T, De Luca A, Bonifazi P, Montagnoli C, Bozza S, Moretti S, Belladonna ML, Vacca C, Conte C, Mosci P, et al.: IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 37(10):2695-2706, 2007.
11. Volman TJ, Hendriks T, Goris RJ: Zymosan-induced generalized inflammation: experimental studies into mechanisms leading to multiple organ dysfunction syndrome. Shock 23(4):291-297, 2005.
12. Lehrer RI, Cline MJ: Interaction of Candida albicans with human leukocytes and serum. J Bacteriol 98(3):996-1004, 1969.
13. Van Der Graaf CA, Netea MG, Verschueren I, Van Der Meer JW, Kullberg BJ: Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae. Infect Immun 73(11):7458-7464, 2005.
14. Jansen MJ, Hendriks T, Verhofstad AA, Lange W, Geeraedts LM Jr, Goris RJ: Gradual development of organ damage in the murine zymosan-induced multiple organ dysfunction syndrome. Shock 8(4):261-267, 1997. (Pubitemid 127654336)
15. Kullberg BJ, Van 't Wout JW, Hoogstraten C, Van Furth R: Recombinant interferon-g enhances resistance to acute disseminated Candida albicans infection in mice. J Infect Dis 168(2):436-443, 1993.
16. Vonk AG, Wieland CW, Netea MG, Kullberg BJ: Phagocytosis and intra-cellular killing of Candida albicans blastoconidia by neutrophils and macro-phages: a comparison of different microbiological test systems. J Microbiol Methods 49(1):55-62, 2002.
17. Kullberg BJ, Van 't Wout JW, Hoogstraten C, Van Furth R: Recombinant interferon-gamma enhances resistance to acute disseminated Candida albicans infection in mice. J Infect Dis 168(2):436-443, 1993.
18. Vonk AG, Netea MG, Van Krieken JH, Iwakura Y, Van Der Meer JW, Kullberg BJ: Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis. J Infect Dis 193(10):1419-1426, 2006.
19. Netea MG, Demacker PNM, Kullberg BJ, Boerman OC, Verschueren I, Stalenhoef AFH, Van Der Meer JWM: Low-density-lipoprotein receptor deficient mice are protected against lethal endotoxinemia and severe Gram-negative infections. J Clin Invest 97(6):1366-1372, 1996.
20. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, Sallusto F, Napolitani G: Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8(6):639-646, 2007.
21. Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, Kanno Y, Spalding C, Elloumi HZ, Paulson ML, et al.: Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452(7188):773-776, 2008.
22. Eyerich K, Foerster S, Rombold S, Seidl HP, Behrendt H, Hofmann H, Ring J, Traidl-Hoffmann C: Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J Invest Dermatol 128(11):2640-2645, 2008.
23. McGeachy MJ, Cua DJ: Th17 cell differentiation: the long and winding road. Immunity 28(4):445-453, 2008.
24. Pirofski LA, Casadevall A: Rethinking T cell immunity in oropharyngeal can-didiasis. J Exp Med 206(2):269-273, 2009.
25. Volman TJ, Goris RJ, Van Der Jagt M, Van De Loo FA, Hendriks T: Organ damage in zymosan-induced multiple organ dysfunction syndrome in mice is not mediated by inducible nitric oxide synthase. Crit Care Med 30(7): 1553-1559, 2002.
26. Leibundgut-Landmann S, Gross O, Robinson MJ, Osorio F, Slack EC, Tsoni SV, Schweighoffer E, Tybulewicz V, Brown GD, Ruland J, et al.: Syk-and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 8(6):630-638, 2007.
27. Veldhoen M, Hocking RJ, Flavell RA, Stockinger B: Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat Immunol 7(11): 1151-1156, 2006.
28. Spellberg B, Ibrahim AS, Edwards JE Jr, Filler SG: Mice with disseminated candidiasis die of progressive sepsis. J Infect Dis 192(2):336-343, 2005.
29. Netea MG, Van Tits LJH, Curfs JHAJ, Amiot F, Meis JFGM, Van Der Meer JWM, Kullberg BJ: The increased susceptibility of TNFaLTa double knockout mice to systemic candidiasis is due to defective recruitment and phagocytosis by neutrophils. J Immunol 163:1498-1505, 1999.